Selenium nanoparticles decorated with Ulva lactuca polysaccharide potentially attenuate colitis by inhibiting NF-κB mediated hyper inflammation

Autor: Qinjie Ling, Jun Li, Chengwei Song, Chenghui Zhu, Shuimei Zhang, Peter R. Hoffmann, Tianfeng Chen, Yibo Zhang, Zhi Huang, Wenjie Zheng
Rok vydání: 2017
Předmět:
Male
0301 basic medicine
Antioxidant
Selenium nanoparticles (SeNPs)
Colon
medicine.medical_treatment
Anti-Inflammatory Agents
Biomedical Engineering
Pharmaceutical Science
Medicine (miscellaneous)
Bioengineering
Inflammation
02 engineering and technology
Biology
Pharmacology
Applied Microbiology and Biotechnology
Mice
Selenium
Ulva
03 medical and health sciences
chemistry.chemical_compound
Ulva lactuca polysaccharide (ULP)
Polysaccharides
medicine
Animals
Colitis
Acute colitis
Selenium (Se)
CD68
business.industry
Research
NF-kappa B
NF-κB
Nuclear factor κ-B (NF-κB)
021001 nanoscience & nanotechnology
medicine.disease
NFKB1
Molecular medicine
Biotechnology
Mice
Inbred C57BL

030104 developmental biology
chemistry
Nanoparticles
Inflammatory bowel diseases (IBD)
Molecular Medicine
medicine.symptom
0210 nano-technology
business
Zdroj: Journal of Nanobiotechnology
ISSN: 1477-3155
DOI: 10.1186/s12951-017-0252-y
Popis: Background Selenium (Se) is an essential micronutrient trace element and an established nutritional antioxidant. Low Se status exacerbates inflammatory bowel diseases progression, which involves hyper inflammation in the digestive tract. Se nanoparticles (SeNPs) exhibit anti-inflammatory activity accompanied by low toxicity, especially when decorated with natural biological compounds. Herein, we explored the beneficial effects of SeNPs decorated with Ulva lactuca polysaccharide (ULP) in mice subjected to the acute colitis model. Results We constructed SeNPs coated with ULP (ULP-SeNPs) in average diameter ~130 nm and demonstrated their stability and homogeneity. Supplementation with ULP-SeNPs (0.8 ppm Se) resulted in a significant protective effect on DSS-induced acute colitis in mice including mitigation of body weight loss, and colonic inflammatory damage. ULP-SeNPs ameliorated macrophage infiltration as evidenced by decreased CD68 levels in colon tissue sections. The anti-inflammatory effects of ULP-SeNPs were found to involve modulation of cytokines including IL-6 and TNF-α. Mechanistically, ULP-SeNPs inhibited the activation of macrophages by suppressing the nuclear translocation of NF-κB, which drives the transcription of these pro-inflammatory cytokines. Conclusions ULP-SeNPs supplementation may offer therapeutic potential for reducing the symptoms of acute colitis through its anti-inflammatory actions. Electronic supplementary material The online version of this article (doi:10.1186/s12951-017-0252-y) contains supplementary material, which is available to authorized users.
Databáze: OpenAIRE